Authors
Loading...
Review reveals how senescence-associated secretory phenotype drives arterial disease during aging, highlighting senescent cell targeting as a promising cardiovascular therapy.
Sun et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: